Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Quality main issue in...

    Quality main issue in prescribing generic drugs: CII president Shobana Kamineni

    Written by Ruby Khatun Khatun Published On 2017-05-14T10:44:55+05:30  |  Updated On 14 May 2017 10:44 AM IST
    Quality main issue in prescribing generic drugs: CII president Shobana Kamineni

    New Delhi: Sounding a note of caution on the MCI move asking doctors to prescribe only generic medicines, CII President Shobana Kamineni has said poor quality of drugs could be dangerous for patients.


    Kamineni, who is also Executive Vice Chairperson of Apollo Hospitals Enterprises, pitched for making India a major medical tourism destination to "heal the world".


    During an interaction with , she also made a strong case for promoting traditional medicines like Ayurveda.


    On the contentious issue of doctors being asked to prescribe generic medicines instead patented drugs, Kamineni said the real problem is quality of drugs.


    "If the generics are high quality, yes. Quality is the main thing. You cannot inject something that is not good quality... People can take the wrong thing. That's also a danger," said the first woman president of the leading industry chamber.


    She said that for pharmacist, who are only diploma holders, it would not be easy to interpret the right mixture of salts and molecules of a generic drugs.


    "It's important that a via media is found... If we need to create more access to health care, let us find the way. But let us find the safe way," she added.


    Observing the cost of health care is low in India in comparison to developed world, the CII president said the country has an unique opportunity to become hub of medical tourism.


    The Medical Council of India (MCI) has advised doctors to prescribe medicines by generic names in place of brand names.


    While generics have established bioequivalence with the originators' products, similars have not.


    The Indian Pharmaceutical Alliance (IPA) patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines.


    Kamineni, whose group firm Apollo Pharmacy is among the biggest organised chemists in the country, said alopathy doctors are not allowed to prescribe Ayurvedic medicines.


    "We have science in Ayurveda. We have science in Yoga and we should celebrate that," she said. NKD RKL CS SA

    Apollo Hospitals EnterprisesAyurvedaCIIgeneric drugsIndian Pharmaceutical AllianceIPAissueMCIMedical Council of IndiaMedical TourismpharmacistQualityShobana Kaminenitraditional medicines
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok